We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

N-Nitroso Atorvastatin

Chemical Structure
Specifications
Product name
N-Nitroso Atorvastatin
SRC CAT No
SRC-N014214
CAS No
NA
Mol.F.
C33H34FN3O6
Mol.Wt.
587.6
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-4-(nitroso(phenyl)carbamoyl)-3-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid

HSN Code
38229010
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Atorvastatin is commonly used to lower bad cholesterol levels (LDL-C) and fats (triglycerides) in the blood. It also increases good cholesterol levels (HDL). Improving your cholesterol levels helps decrease your risk of heart disease, stroke, and heart attack.N-Nitroso Atorvastatin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

N-Nitroso Atorvastatin CAS NO:NA  chemically represented as (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-4-(nitroso(phenyl)carbamoyl)-3-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid. Synchemia is the leading manufacturing and exporter of N-Nitroso Atorvastatin. We supply N-Nitroso Atorvastatin with detailed characterization data compliance with regulatory guidelines.